Company / Operating Margin
AXIM BIOTECHNOLOGIES, INC. Operating Margin History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-6961.0%
FY2023
5-year range
-52425.6% / -2574.5%
FY2019-FY2023
Trend
+86.7%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -2574.5% to -6961.0% over the past 5 years.
Based on SEC 10-K filings.
-6961.0% in FY2023 with a 5-year CAGR of -4386.5%.
Declined from -2574.5% to -6961.0% over the past 5 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -4386.5pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2023, operating margin increased 86.7% year-over-year.
- Peak operating margin was recorded in FY2018.
- Lowest operating margin in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -6961.0% | +86.7% |
| FY2022 | -52425.6% | -1936.3% |
| FY2018 | -2574.5% | +61.1% |
| FY2017 | -6619.5% | +17.1% |
| FY2016 | -7988.8% | +60.9% |
| FY2015 | -20451.3% | - |
| FY2013 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026